CRISPR hybrid DNA/RNA polynucleotides and methods of use
US9688972B2 · kind B2 · utility
26Cited by
13References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2017 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | Jan 18, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure provides DNA-guided CRISPR systems; polynucleotides comprising DNA, RNA and mixtures thereof for use with CRISPR systems; and methods of use involving such polynucleotides and DNA-guided CRISPR systems.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.